Atherosclerotic plaque burden reduction in Native and Intervened coronary arteries as well as in other Major arteries by High Dose ATorvastatin ThErapy-A double blind, randomized study (ANIMATE)
Phase of Trial: Phase III
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Atorvastatin (Primary)
- Indications Atherosclerosis; Coronary artery disease
- Focus Therapeutic Use
- Acronyms ANIMATE
- 16 Apr 2012 New source identifed and integrated (Chinese Clinical Trials Register record ChiCTR-TRC09000649).
- 05 Nov 2010 New trial record.